Girentuximab Vedotin Biosimilar - Research Grade
Product Specifications
Background
Anti-CAIX Reference Antibody (girentuximab-MMAE) (CHB293) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 144.62 kDa.
Product Name Alternative
MMAE
Host
CHO Cells
Reactivity
Human
Target
CA9 / Carbonic anhydrase 9
Isotype
IgG1
Applications
Functional Assays
Concentration
1mg/mL
Purity
>90% by SDS-PAGE
Shipping Conditions
Room Temp
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Formulation
25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Applications Notes
Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.
Isotype Control
Bulk Human IgG1 Isotype Control (IB1) [ICH2254]
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2029692-01 0.01 mg
Recombinant Receptor Activator Of Nuclear Factor Kappa B Ligand (RANkL)
Sign In for Pricing
View Details 
MBS2029692-02 0.05 mg
Recombinant Receptor Activator Of Nuclear Factor Kappa B Ligand (RANkL)
Sign In for Pricing
View Details MBS2029692-03 0.1 mg
Recombinant Receptor Activator Of Nuclear Factor Kappa B Ligand (RANkL)
Sign In for Pricing
View Details 
MBS2029692-04 0.2 mg
Recombinant Receptor Activator Of Nuclear Factor Kappa B Ligand (RANkL)
Sign In for Pricing
View Details 
MBS2029692-05 0.5 mg
Recombinant Receptor Activator Of Nuclear Factor Kappa B Ligand (RANkL)
Sign In for Pricing
View Details MBS2029692-06 1 mg
Recombinant Receptor Activator Of Nuclear Factor Kappa B Ligand (RANkL)
Sign In for Pricing
View Details